uk
nation
blood
servic
introduc
polici
male
donor
prefer
involv
women
plasma
discard
follow
blood
collect
polici
base
view
data
relat
incid
transfusionrel
acut
lung
injuri
trali
link
transfus
women
plasma
appear
treat
femal
donor
equal
male
donor
exclus
criteria
oper
donat
stage
process
blood
thu
perpetu
myth
univers
even
though
certain
extract
women
retain
use
transfus
mani
women
uk
receiv
plasmaderiv
product
call
antid
immunoglobulin
manufactur
pool
male
plasma
articl
examin
way
gender
signific
understand
blood
relat
blood
economi
gender
studi
relat
blood
donor
recipi
explor
gender
bodi
produc
discurs
materi
practic
within
blood
servic
examin
donat
polici
manufactur
use
blood
product
produc
gender
blood
relat
articl
examin
way
gender
signific
understand
blood
relat
blood
economi
gender
previous
recognis
wider
bioeconomi
gender
practic
mobilis
women
reproduct
tissu
exampl
oocyt
fetal
tissu
embryo
cord
blood
use
sourc
stem
cell
kent
waldbi
waldbi
cooper
ova
exchang
therapeut
treatment
infertil
frame
enabl
women
assist
other
children
also
reproduc
racialis
nation
ideal
konrad
nahman
although
data
organ
transplant
identifi
women
compris
major
donor
also
reveal
men
much
like
becom
organ
recipi
jindal
et
al
studi
shown
bodi
becom
plastic
flexibl
exchang
biolog
materi
becom
increasingli
associ
new
form
biolog
citizenship
capit
accumul
rose
nova
studi
relat
blood
donor
recipi
explor
gender
bodi
produc
discurs
materi
practic
within
nation
blood
servic
anthropolog
studi
sociocultur
mean
ethic
blood
donat
drawn
attent
complex
blood
relat
highlight
divers
across
commun
within
differ
cultur
nation
religi
polit
context
copeman
mauss
mauss
titmuss
claim
ethic
imper
whole
blood
donat
nation
blood
servic
conceptualis
use
notion
gift
relationship
involv
altruist
donat
blood
without
financi
reward
seen
prefer
moral
choic
underpin
social
contract
bound
commun
togeth
titmuss
concept
gift
relationship
underpin
appeal
univers
seen
import
act
social
biolog
citizenship
promot
part
nation
blood
servic
provid
moral
institut
basi
encourag
blood
donat
organis
manner
heali
critic
understand
blood
donat
associ
concept
citizenship
solidar
altruism
sinc
develop
blood
donat
demonstr
highli
politicis
issu
especi
tension
arisen
due
social
group
exclud
donor
polici
donor
deferr
commonli
justifi
polici
maker
ground
ensur
blood
safeti
controversi
increasingli
subject
critic
scrutini
practic
public
health
object
ensur
safe
blood
suppli
underli
safeti
logic
hoeyer
meant
claim
univers
blood
donat
conting
donor
deferr
exclus
institut
nation
blood
servic
rang
scientif
social
institut
reason
deserv
analysi
potenti
donor
refus
permiss
donat
reason
may
vari
across
state
boundari
regulatori
regim
cultur
more
yet
exclus
frequent
obscur
discours
univers
blood
donat
underexplor
notion
citizenship
valentin
point
univers
blood
implicitli
sometim
explicitli
equat
univers
possibl
donat
even
though
exclus
creat
categori
quit
citizen
gender
bodi
tradit
render
women
quit
citizen
least
differ
kind
citizen
deferr
men
sex
men
msm
becom
donor
foreground
link
sexual
ident
blood
donat
martucci
valentin
connect
gender
less
well
elabor
rather
commonli
assum
heterosexu
men
women
equal
valu
blood
donor
especi
western
blood
economi
argu
far
case
articl
focus
primarili
current
polici
practic
uk
analys
intern
blood
donat
polici
clinic
scientif
literatur
draw
public
tour
major
blood
process
facil
field
visit
plasma
product
manufactur
interview
transfus
specialist
repres
patient
group
plasma
industri
part
larger
project
consent
risk
safeti
uk
blood
servic
research
rais
question
contemporari
practic
within
blood
servic
plasma
industri
women
presum
repres
threat
safeti
plasma
transfus
becom
pregnant
gender
ident
map
onto
discours
risk
safeti
understand
patholog
bodi
context
men
unless
previous
transfus
presum
low
normal
antibodi
level
given
uncertainti
caus
particular
complic
plasma
transfus
known
transfusionrel
acut
lung
injuri
trali
polit
condit
contribut
strategi
exclud
women
plasma
donor
transfus
uk
elsewher
extent
potenti
risk
trali
associ
transfus
femal
plasma
prioritis
potenti
benefit
claim
cardiac
patient
transfus
femal
plasma
better
outcom
question
mind
conclud
blood
relat
gender
transfus
scienc
produc
gender
bodi
technolog
plasma
fraction
shape
gender
inequ
order
explor
argument
articl
first
discuss
signific
gender
blood
plasma
donat
look
gender
relat
structur
product
use
plasmaderiv
product
antid
immunoglobulin
antid
ig
treatment
parturi
women
prevent
haemolyt
diseas
fetu
newborn
hdfn
feminist
analys
drawn
attent
way
gender
inequ
obscur
universalis
narr
liber
humanist
subject
modernist
scienc
onward
studi
explor
aspect
women
health
elabor
way
contemporari
biomedicin
perpetu
masculinist
notion
healthi
bodi
neglect
specif
women
experi
ill
health
pathologis
pregnanc
childbirth
see
exampl
martin
health
servic
shown
institutionalis
discriminatori
practic
perpetu
health
social
inequ
focu
embodi
live
experi
gender
aspect
health
ill
describ
essentialist
read
gender
bodi
increasingli
becam
problematis
understand
bodi
naturalis
biolog
given
seen
unsatisfactori
instead
account
multipl
sociohistor
cultur
process
produc
bodi
bodili
differ
highlight
conting
uncertain
leaki
boundari
bodi
shildrick
regul
disciplin
product
bodi
biomed
scienc
becam
clearli
recognis
polit
project
part
new
kind
vital
polit
biopolit
rose
biopow
seen
product
follow
haraway
other
entangl
biolog
polit
becom
evid
includ
theori
immun
system
martin
transplant
scienc
shildrick
regen
medicin
kent
argu
transfus
scienc
short
contemporari
theoris
gender
rais
number
question
gender
differ
enact
blood
servic
materi
discurs
practic
transfus
scienc
discours
truth
regim
creat
translat
rule
clinic
practic
industri
standard
blood
servic
underpin
organis
deliveri
servic
also
global
plasma
product
industri
gender
bodi
naturalis
made
invis
discours
draw
heavili
universalis
myth
seek
valu
blood
plasma
donat
social
public
good
tie
donat
citizenship
social
solidar
also
assum
bioavail
cohen
equalis
effect
wherebi
donat
equal
valu
despit
evid
contrari
discuss
detail
later
conceptu
approach
see
polici
practic
within
blood
servic
plasma
product
industri
situat
bodi
differ
way
msm
donor
donor
histori
transfus
donor
bodi
risk
variant
creutzfeldtjakob
diseas
vcjd
femal
male
donor
racialis
bodi
blood
servic
plasma
product
industri
produc
differ
develop
categori
sort
screen
test
match
evalu
donor
recipi
bodi
white
male
donor
bodiessymbolis
typic
blood
donor
nation
blood
serviceshav
come
view
superior
sourc
blood
plasma
product
context
meet
increas
demand
blood
scarciti
endur
problem
blood
servic
attract
loyal
popul
repeat
donor
give
blood
regular
basi
import
address
problem
enhanc
blood
safeti
bonig
et
al
signific
literatur
examin
motiv
behaviour
donor
popul
view
understand
best
retain
masser
et
al
draw
attent
number
women
inelig
becom
donor
evid
women
less
like
becom
donor
heali
see
organis
cultur
factor
rather
individu
motiv
shape
donor
popul
typic
blood
donor
western
blood
economi
commonli
male
white
educ
age
averag
occup
level
incom
piliavin
callero
like
involv
civic
engag
activ
alessandrini
discuss
previous
farrel
techniqu
risk
assess
risk
manag
underpin
intern
govern
blood
suppli
order
promot
blood
safeti
howev
risk
unstabl
concept
defin
vari
way
risk
assess
view
domain
scientif
expert
risk
manag
matter
polit
leadership
role
scienc
polit
risk
govern
much
debat
simpl
term
view
risk
object
knowabl
phenomenon
measur
wherea
other
social
construct
influenc
cultur
institut
polit
context
farrel
take
view
risk
inde
sociocultur
construct
shape
polit
wider
institut
process
use
classificatori
technolog
identifi
potenti
risk
blood
suppli
must
view
one
way
dynam
oper
other
suggest
transplant
medicin
produc
reifi
biocultur
categori
racial
ethnic
differ
use
blood
group
antigen
human
leucocyt
antigen
hla
match
criteria
organ
transplant
way
discriminatori
perpetu
social
inequ
kieran
cooper
suggest
similar
process
oper
within
transfus
scienc
valuat
bodili
materi
variabl
gender
highlight
women
bodi
construct
riski
number
way
nation
blood
servic
relat
use
femal
plasma
transfus
manufactur
blood
product
known
antid
ig
case
male
bodi
highli
valu
term
sourc
materi
provid
blood
compon
product
collect
suppli
blood
use
product
rang
compon
plasma
product
becom
complex
undertak
nation
blood
servic
see
figur
one
hand
characteris
endur
sociocultur
polit
concern
prefer
method
collect
line
nation
prefer
often
crystallis
support
gift
relationship
western
bioeconomi
hand
concern
must
manag
context
interconnected
within
across
nation
boundari
relat
collect
suppli
waldbi
mitchel
shift
time
space
face
emerg
risk
blood
safeti
well
relat
chang
market
demand
blood
compon
plasma
product
layer
complex
ad
mix
collect
manufactur
practic
differ
blood
compon
plasma
product
forprofit
notforprofit
organis
involv
practic
figur
fresh
blood
compon
plasmaderiv
recombin
product
sourc
wwwbloodgovauaboutblood
talk
blood
product
plasma
product
differ
talk
labil
blood
product
go
mainli
use
transfus
purpos
talk
plasma
product
basic
product
finish
pharmaceut
product
undergon
manufactur
cycl
stabl
product
much
longer
shelflif
product
circul
intern
level
wherea
labil
blood
product
tend
product
much
shorter
shelflif
use
nation
scale
one
key
differ
anoth
differ
would
say
lie
collect
practic
blood
plasma
product
blood
product
obvious
come
blood
donat
made
blood
donor
plasma
product
plasma
product
use
global
scale
come
plasmapharesi
donor
peopl
actual
donat
plasma
whole
blood
go
specialis
plasmapharesi
centr
account
approxim
percent
plasma
use
therapeut
purpos
global
scale
percent
remain
plasma
come
plasma
recov
blood
donat
int
execut
intern
patient
organis
uk
blood
donat
polici
use
plasma
product
shape
concern
potenti
risk
transmiss
prion
diseas
vcjd
explain
plasma
obtain
male
whole
blood
donor
may
use
produc
fresh
frozen
plasma
ffp
transfus
adult
british
plasma
use
manufactur
plasma
product
consequ
mani
plasma
product
ton
plasma
use
uk
plasma
product
manufactur
import
polici
regard
silli
anoth
respond
saw
blood
plasma
donat
europ
differ
european
countri
get
plasma
volunt
nonremuner
donor
way
get
safe
plasma
suppli
pay
donor
unfortun
britain
import
plasma
hundr
thousand
hundr
ton
plasma
donor
us
disgrac
word
undermin
selfsuffici
europ
say
silli
rule
use
british
plasma
int
intern
donor
organis
principl
nation
selfsuffici
blood
suppli
plasma
product
consid
import
way
maximis
blood
safeti
plasma
manufactur
explain
manufactur
process
advanc
plasma
product
safe
safe
term
viral
transmiss
term
infect
product
safe
int
plasma
manufactur
describ
us
donor
manag
programm
enhanc
safeti
profil
sourc
plasma
within
global
industri
respect
prevent
transmiss
prion
implic
vcjd
view
technolog
remov
develop
would
need
suitabl
use
largescal
manufactur
process
therefor
govern
risk
blood
servic
plasma
industri
pose
technic
challeng
also
rais
ethic
polit
concern
commonli
express
view
typic
europ
pay
donor
increas
potenti
threat
blood
safeti
uneth
moral
issu
deepli
entwin
construct
risk
safeti
mani
nation
blood
servic
found
voluntari
unremuner
donat
closer
analysi
literatur
reveal
within
transfus
scienc
blood
polici
categori
donor
recipi
bodi
construct
moral
hierarchi
scale
exchang
use
valu
exclud
msm
migrant
donor
segreg
blood
along
racial
line
countri
bekker
wood
martucci
starr
valentin
polonski
et
al
say
instanc
gift
blood
offer
way
citizen
liter
becom
part
nation
imagin
link
countrymen
could
blood
brother
feel
social
includ
part
polit
process
interestingli
attend
exclus
migrant
peopl
citizenship
statu
polonski
et
al
fail
recognis
gender
notion
citizenship
oper
exampl
societi
marriag
key
sourc
statu
secur
women
carrier
thalassemia
marginalis
social
exclud
chattopadhyay
context
women
reproduct
role
continu
associ
social
exclus
marginalis
render
quit
citizen
studi
highlight
gender
blood
donat
brazil
third
donor
women
donat
understood
form
bloodlet
use
hormon
contracept
suppress
menstruat
sanabria
pakistan
women
blood
regard
impur
expect
donat
blood
except
men
avail
mumtaz
et
al
experi
blood
donat
gender
blood
may
seen
self
alien
render
nonself
follow
manipul
transfus
notion
blood
becom
anonymis
product
distinctli
masculin
idea
among
regular
blood
donor
eight
nine
male
blood
donor
use
version
model
understand
gave
blood
wherea
femal
donor
except
nurs
inclin
think
blood
form
relationship
recipi
either
kind
loan
share
substanc
waldbi
et
al
waldbi
et
al
evid
indic
women
construct
differ
kind
donor
patientrecipi
relat
assess
risk
within
blood
economi
describ
gender
ident
blood
travel
process
centr
matern
bodi
repres
threat
blood
plasma
product
safeti
uk
blood
collect
organis
four
nation
blood
servic
base
unpaid
anonymis
voluntari
donat
alongsid
collect
whole
blood
global
plasma
product
industri
plasma
product
manufactur
obtain
plasma
sourc
compani
well
recov
plasma
whole
blood
collect
blood
servic
hospit
figur
plasma
product
export
around
world
treatment
divers
medic
condit
much
plasma
collect
us
paid
individu
number
countri
benelux
region
oper
notforprofit
basi
sourc
plasma
voluntari
nonremuner
donor
demand
plasma
plasmaderiv
product
increas
one
estim
put
global
demand
plasma
fraction
figur
million
litr
omahoni
turner
plasma
suppli
price
sensit
maintain
suppli
plasma
donor
blood
donor
key
prioriti
nation
govern
industri
uk
plasma
sourc
us
use
fraction
sinc
exclus
uk
donor
product
plasma
product
ten
year
ago
howev
suppli
ffp
obtain
whole
blood
donat
within
uk
blood
servic
part
unlik
statesponsor
blood
servic
emphasis
ethic
voluntar
altruism
forprofit
plasma
product
industri
made
claim
univers
social
citizenship
solicit
plasma
donat
inde
predominantli
usbas
industri
tradit
reli
socioeconom
disadvantag
marginalis
provid
plasma
regular
basi
return
cash
histor
women
plasma
valu
carri
high
titr
rhd
antibodi
use
manufactur
antid
ig
industri
shown
long
stand
prefer
male
plasma
target
prison
inmat
mental
institut
gay
men
antibodi
need
manufactur
particular
product
gamma
globulin
hepat
b
vaccin
starr
donor
complianc
reduc
riski
behaviour
heart
plasma
procur
practic
today
industri
standard
appli
procur
process
manufactur
plasma
intend
reduc
risk
transmiss
infect
viral
diseas
improv
qualiti
safeti
product
farrel
voluntari
standard
develop
intern
qualiti
plasma
programm
europ
sourc
plasma
must
compli
european
blood
direct
also
stringent
oversight
nation
supran
level
ensur
complianc
manufactur
standard
within
scope
intern
pharmaceut
medicin
product
regul
farrel
want
draw
attent
plasma
technolog
product
inscrib
gender
technolog
risk
calcul
neutral
social
embed
continu
debat
risk
attribut
msm
exclus
blood
tissu
donor
sinc
hiv
crisi
drawn
attent
conting
discriminatori
practic
associ
risk
calculu
involv
blood
safeti
galarneau
hoeyer
within
transfus
scienc
blood
relat
exchang
seen
strong
creat
vital
public
embodi
associ
elicit
gener
exchang
bodi
case
blood
particip
vital
public
might
therefor
seen
uniqu
duti
associ
biolog
citizen
strong
argu
exclus
msm
donor
reli
technolog
first
sought
measur
risk
model
mathemat
yet
assess
risk
transfus
transmit
viral
infect
problemat
social
rel
serv
polit
end
sustain
blood
suppli
protect
public
health
consequ
suggest
polici
mobilis
particular
understand
potenti
risk
use
plasma
women
must
also
view
light
although
women
recruit
whole
blood
donor
donat
differ
exchang
valu
men
despit
appear
univers
blood
donat
uk
blood
servic
introduc
polici
male
donor
prefer
involv
women
plasma
discard
follow
whole
blood
collect
unless
shortag
male
donor
suppli
requir
stock
supplement
polici
base
view
data
relat
incid
trali
link
transfus
plasma
women
chapman
potenti
fatal
syndrom
characteris
name
past
year
definit
subject
intern
debat
discuss
clinic
symptom
breathless
hypoxia
pulmonari
chang
associ
caus
lung
trauma
make
definit
diagnosi
difficult
chapman
et
al
pathogenesi
trali
poorli
understood
shaz
et
al
one
theori
put
forward
relat
interact
donor
hla
antibodi
leucocyt
patient
patient
factor
may
also
signific
specif
diagnost
test
trali
nevertheless
sinc
uk
haemovigli
scheme
seriou
hazard
transfus
shot
record
report
trali
base
recommend
shot
nation
blood
servic
nb
decid
exclud
use
femal
plasma
product
ffp
suspens
buffi
coat
deriv
pool
platelet
far
possibl
part
risk
reduct
strategi
chapman
williamson
shot
introduc
set
four
categori
trali
case
indic
level
uncertainti
diagnosi
highli
like
probabl
possibl
unlik
year
therefor
high
proport
report
trali
case
categoris
possibl
unlik
trali
consensu
confer
canada
describ
clinic
criteria
trali
possibl
trali
presenc
antibodi
femal
plasma
believ
implic
caus
trali
hla
antibodi
product
turn
associ
pregnanc
women
despit
clinic
technic
uncertainti
surround
definit
diagnosi
trali
associ
hla
antibodyposit
femal
donor
led
new
polici
oper
strategi
follow
way
sinc
new
donor
question
introduc
regard
west
nile
viru
sever
acut
respiratori
syndrom
agre
addit
question
would
ask
regard
previou
pregnanc
transfus
result
option
apprais
nb
introduc
octob
polici
use
male
plasma
manufactur
ffp
far
oper
possibl
polici
involv
addit
donor
question
loss
donor
either
whole
blood
apheresi
collect
sinc
plasma
collect
latter
method
fraction
uk
plasma
discontinu
vcjd
plasma
nonffp
donat
discard
chapman
et
al
femal
therefor
defin
risk
factor
similar
way
potenti
prion
transmiss
donor
women
whether
histori
pregnanc
result
new
polici
deem
unfit
least
undesir
plasma
donat
time
onward
whole
blood
donat
label
f
donor
session
easi
identif
process
centr
sinc
percent
ffp
produc
recov
male
plasma
uk
nh
blood
transplant
largest
nation
blood
process
centr
femal
plasma
separ
red
blood
cell
first
stage
process
redirect
discard
section
sent
inciner
risk
factor
associ
reproduct
histori
per
se
reproduct
potenti
materialis
femal
bodi
inher
riski
sourc
plasma
suggest
rather
crude
approach
exclus
femal
plasma
simpl
low
cost
implement
chapman
et
al
moreov
chang
polici
relat
fraction
uk
plasma
wake
vcjd
male
ffp
could
implement
without
loss
donor
without
need
discuss
polici
compani
undertak
fraction
donor
alreadi
awar
plasma
donat
discard
specif
commun
male
plasma
polici
similarli
decis
suspend
bcderiv
plt
buffycoatderiv
pool
platelet
concentr
pool
male
plasma
could
implement
rel
easili
chapman
et
al
although
femal
plasma
discard
first
stage
process
follow
donat
consid
necessari
uk
blood
servic
inform
women
donor
take
place
appear
rationalis
basi
servic
want
advers
affect
willing
donat
blood
presum
women
might
decid
donat
blood
knew
plasma
discard
women
entitl
inform
addit
due
exclus
polici
relat
vcjd
risk
ffp
patient
born
uk
import
sinc
male
donor
us
patient
transfus
uk
plasma
product
deriv
plasma
pool
also
expect
deriv
male
donor
known
donor
henc
staff
process
centr
visit
refer
superior
qualiti
male
plasma
men
donat
short
chang
uk
polici
appear
rais
polit
concern
easili
implement
alongsid
restrict
relat
use
uk
plasma
receiv
public
attent
point
view
uk
blood
servic
easi
discard
femal
plasma
seen
neither
wast
deserv
wider
public
justif
explan
inform
provid
donor
nh
blood
transplant
explain
plasma
use
make
clear
either
plasma
uk
donor
use
fraction
male
prefer
polici
oper
way
women
plasma
seldom
use
separ
blood
cell
plasma
patient
use
goe
one
two
direct
use
blood
transfus
fresh
frozen
plasma
transfus
plasma
product
also
direct
plasma
fraction
plant
undergo
complic
type
process
separ
mani
individu
protein
statement
lack
transpar
appear
deliber
obscur
practic
within
uk
blood
servic
regard
use
plasma
use
femal
plasma
particular
cloak
chang
recognis
uk
donor
implic
risk
transmit
vcjd
therefor
plasma
limit
exchang
valu
specif
gender
polici
relat
plasma
process
effect
obscur
unlik
discrimin
msm
polici
exclus
women
plasma
invis
though
appear
treat
femal
donor
equal
male
donor
exclus
criteria
oper
donat
stage
process
blood
donat
short
serv
perpetu
myth
univers
even
though
realiti
certain
extract
women
retain
use
transfus
women
bioavail
consid
jeopardis
potenti
becom
pregnant
turn
could
increas
antibodi
product
circumst
ffp
pool
platelet
suspens
highli
gender
product
uk
elsewher
strategi
prevent
trali
implement
divers
way
countri
base
differ
interpret
evid
link
femal
donor
plasma
australia
exampl
australian
red
cross
blood
servic
polici
use
predominantli
maleonli
plasma
fresh
plasma
product
publicli
avail
factsheet
cite
uk
experi
evid
base
also
acknowledg
scientif
uncertainti
caus
trali
australian
red
cross
blood
servic
us
account
taken
divers
caus
trali
chapman
scientif
uncertainti
surround
syndrom
us
propos
highlight
need
partial
increment
approach
make
polici
decis
suggest
plasma
divers
strategi
divert
femal
plasma
fraction
use
male
plasma
transfus
sought
avoid
alien
confus
femal
donor
eder
et
al
canada
combin
prefer
male
plasma
transfus
highvolum
plasma
compon
screen
women
histori
pregnanc
thought
improv
transfus
outcom
lin
et
al
measur
design
retain
women
donor
also
adopt
risk
reduct
strategi
yet
one
studi
suggest
cardiac
patient
receiv
femal
plasma
transfus
better
outcom
exclud
femal
plasma
donor
could
detriment
effect
welsbi
et
al
other
argu
evid
support
femal
donor
screen
exclus
shaz
et
al
paradox
gender
ident
ffp
consid
import
relat
trali
recent
studi
use
ffp
england
question
clinic
benefit
data
gender
patient
receiv
collect
stanworth
et
al
yang
et
al
sum
men
women
view
differ
kind
donor
within
transfus
scienc
women
may
regard
potenti
riski
plasma
donor
due
antibodi
statu
presum
blanket
exclus
femal
plasma
wherev
possibl
uk
women
neither
routin
screen
test
antibodi
statu
contrast
western
countri
use
differ
approach
one
redirect
rather
discard
femal
plasma
screen
women
donor
pregnanc
histori
matern
bodi
matern
repres
potenti
threat
safeti
plasma
suppli
far
consid
gender
donat
gender
transfus
practic
howev
extend
women
recipi
blood
plasma
product
particularli
obstetr
context
specif
implic
pregnanc
women
need
transfus
plasma
product
well
statu
blood
plasma
donor
defin
featur
blood
relat
case
becom
pregnant
miscarriag
abort
women
interest
treatment
rel
small
group
women
blood
type
rhd
neg
estim
white
uk
popul
nice
pilgrim
et
al
wider
signific
women
posit
within
blood
economi
pregnanc
woman
rhd
neg
fetu
rhd
posit
fetal
matern
haemorrhag
occur
fetal
cell
cross
placenta
may
stimul
antibodi
product
caus
rh
hdfn
potenti
fatal
blood
disord
nh
blood
transplant
product
hla
antibodi
woman
known
sensitis
may
particularli
seriou
consequ
subsequ
pregnanc
therefor
administr
plasma
product
antid
ig
design
prevent
sensitis
antibodi
product
antid
ig
administ
prophylact
antenat
postnat
follow
sensitis
event
may
caus
fetal
matern
haemorrhag
might
includ
miscarriag
abort
intrauterin
test
trauma
although
antid
ig
use
prophylact
treatment
year
mani
western
countri
kumpel
kumpel
kumpel
elson
mechan
passiv
immunis
poorli
understood
efficaci
differ
treatment
well
studi
pilgrim
et
al
nevertheless
consid
highli
success
reduc
incid
hdfn
patern
blood
group
test
may
assist
identifi
women
risk
becom
sensitis
new
technolog
antenat
test
involv
cell
free
fetal
dna
cffdna
circul
matern
blood
genotyp
potenti
identifi
blood
group
fetu
therefor
determin
whether
need
prophylact
administr
brojer
et
al
nice
date
test
becom
wide
avail
risk
women
howev
risk
women
associ
use
antid
ig
incorrect
administr
mani
women
receiv
product
unnecessarili
boltonmagg
et
al
fin
et
al
kent
et
al
ireland
larg
number
women
infect
hepat
c
hcv
result
receiv
contamin
antid
ig
product
manufactur
blood
transfus
servic
board
btsb
ran
nation
blood
servic
time
antid
ig
question
sourc
two
femal
irish
donor
receiv
plasma
exchang
treatment
btsb
commit
achiev
nation
selfsuffici
blood
plasma
product
fail
withdraw
product
even
charg
servic
becam
awar
variou
batch
like
contamin
hepat
follow
introduct
test
blood
donat
hcv
earli
case
involv
women
blood
donor
hcvposit
emerg
lead
investig
reveal
extent
hcv
contamin
antid
ig
highprofil
polit
scandal
follow
posit
action
support
group
women
affect
contamin
success
lobbi
govern
comprehens
health
care
packag
tribun
establish
award
financi
compens
harm
suffer
posit
action
irish
govern
also
conven
tribun
inquiri
found
clear
contravent
polici
guidelin
relat
way
blood
collect
sourc
materi
antid
ig
protocol
use
manufactur
product
btsb
tribun
inquiri
programm
trace
identifi
women
receiv
hcvcontamin
antid
ig
found
women
hcv
antibodi
posit
posit
polymeras
chain
reaction
test
viral
type
consist
infect
antid
ig
irish
blood
transfus
servic
irish
case
highlight
consequ
viral
transmiss
plasma
product
time
new
technolog
viral
test
emerg
vulner
pregnant
women
receiv
antid
ig
therapi
use
antid
ig
uk
use
antid
ig
uk
today
rais
complex
safeti
issu
risk
women
relat
misus
product
advers
event
involv
administr
product
report
shot
shot
sixti
women
receiv
antid
ig
given
case
omit
given
later
recommend
one
interviewe
note
good
friend
mine
midwif
regularli
administ
antid
ask
understand
pool
blood
product
one
patient
ask
risk
would
know
nt
int
govern
advis
recent
administr
antid
ig
becom
target
train
midwiv
shortli
subject
nation
audit
uk
although
direct
health
benefit
women
routin
administr
antid
ig
despit
critic
wickham
prevent
hdfn
remain
prioriti
justif
use
hark
hark
et
al
nice
howev
current
uk
guidelin
recommend
rhd
neg
women
offer
prophylact
antid
ig
mean
carri
rhd
neg
fetu
approxim
women
per
year
receiv
product
unnecessarili
fin
et
al
antid
ig
commerci
produc
larg
market
cost
health
servic
routin
antenat
antid
prophylaxi
high
nice
sinc
administr
antid
ig
becam
routin
number
sensitis
women
whose
blood
may
use
sourc
materi
product
reduc
antid
ig
current
commerci
produc
predominantli
male
bodi
male
plasma
donor
well
known
sourc
compani
well
characteris
plasma
constitut
pool
potenti
antid
donor
select
paid
premium
receiv
repeat
dose
rhd
posit
red
blood
cell
stimul
immun
respons
produc
antibodi
harvest
next
plasma
donat
antid
ig
manufactur
pool
plasma
men
use
women
may
also
use
infrequ
case
rhd
neg
men
wrongli
transfus
rhd
posit
blood
procedur
unusu
number
respect
activ
intervent
bodi
male
plasma
donor
stimul
antibodi
product
second
attract
market
premium
tie
scheme
incent
men
donat
plasma
unavail
paid
women
donor
unless
older
postmenopaus
though
use
higher
price
paid
plasma
reflect
potenti
risk
male
donor
also
higher
valu
place
bodili
product
women
produc
antibodi
natur
result
pregnanc
exclud
women
reproduct
age
regard
high
risk
sensitis
could
advers
impact
futur
pregnanc
technolog
produc
monoclon
synthet
antid
ig
develop
current
commerci
viabl
kumpel
kumpel
interview
reveal
transact
men
women
technolog
mediat
technolog
embed
within
gender
blood
economi
male
bodi
sourc
plasma
plasma
protein
product
commerci
avail
antid
ig
shape
immunopolit
merit
closer
analysi
transfus
scienc
draw
set
ration
immun
system
emerg
within
specif
gender
histor
context
haraway
biomed
bodi
convent
seen
repres
nationst
invad
organ
foreign
recent
scientif
cultur
understand
see
immun
system
complex
network
system
martin
within
framework
matern
bodi
particular
often
repres
paradox
explan
genet
distinct
fetu
reject
mother
provok
consider
debat
stimul
long
histori
investig
pregnanc
fetal
matern
circul
increasingli
understood
close
interconnect
matern
fetal
microchimer
refer
mix
cell
matern
fetal
bodi
kelli
martin
placent
border
cross
may
provok
immunolog
respons
kelli
account
emerg
gestat
cell
transfer
scienc
understand
maternalfet
microchimer
reveal
extent
scientif
uncertainti
signific
mean
exchang
previous
thought
patholog
fetal
cell
enter
matern
circul
recent
consid
normal
biolog
intrins
branch
polit
discours
construct
constitut
polit
subject
kelli
immunolog
theori
support
reinforc
set
polit
valu
normal
patholog
state
subject
ident
fetu
thought
hostil
invad
intrud
placenta
barrier
two
separ
selv
martin
domin
view
immun
system
defend
self
pure
bodi
normal
bodi
kelli
recognit
cell
routin
cross
placent
interfac
relat
model
immun
system
begin
emerg
complex
dynam
network
haraway
instead
barrier
placenta
may
view
permeabl
interfac
exchang
mother
fetu
occur
direct
bidirect
cell
traffick
martin
discoveri
intermingl
matern
fetal
circul
blood
type
incompat
caus
hdfn
import
develop
antid
ig
therapi
implic
revis
model
immun
system
relat
network
much
wider
first
notion
bodi
chimer
undermin
notion
modern
polit
subject
distinct
individu
kelli
second
impli
differ
way
think
antibodi
signific
transfus
practic
start
seem
far
complex
blanket
exclus
women
plasma
donor
uk
suggest
yet
context
transfus
scienc
presum
immun
statu
women
compromis
potenti
exposur
fetal
bodi
therebi
affect
suitabl
becom
plasma
donor
contrast
commerci
product
antid
ig
inject
male
rhd
neg
plasma
donor
rhd
posit
cell
produc
antibodi
accept
valu
practic
read
uk
male
prefer
polici
plasma
discriminatori
construct
women
riski
plasma
donor
regardless
age
reproduct
histori
antibodi
statu
implement
public
consult
discuss
continu
lack
public
inform
explan
polici
turn
rais
question
ethic
donat
inform
given
women
becom
blood
donor
retain
women
donor
donor
pool
may
import
polici
object
differ
way
donat
process
inform
made
avail
myth
univers
citizenship
solidar
publicli
elabor
upon
explain
justifi
way
women
treat
differ
kind
donor
men
shown
women
unabl
donat
blood
frequent
men
women
plasma
like
discard
uk
elsewher
use
limit
process
fraction
also
shown
antid
ig
produc
mainli
male
bodi
use
pregnant
parturi
women
women
reproduct
age
usual
exclud
becom
donor
product
access
addit
payment
donat
moreov
mani
women
receiv
antid
ig
unnecessari
kent
et
al
short
institut
arrang
plasma
collect
process
favour
donor
men
practic
around
procur
distribut
render
gender
differ
invis
visibl
patient
inform
describ
antid
ig
produc
special
select
donor
nh
blood
transplant
women
often
unawar
may
need
antid
ig
carri
rhd
neg
fetu
plasma
product
simpli
homogen
neutral
univers
technolog
rather
gender
inscrib
upon
gender
differ
produc
within
industri
blood
servic
technolog
risk
assess
also
neutral
calcul
risk
associ
ffp
plasma
transfus
rest
limit
understand
caus
characteris
trali
evid
base
includ
widerang
categoris
highli
like
probabl
possibl
unlik
case
transfus
scienc
discours
truth
power
tie
technolog
chang
emerg
form
knowledg
expertis
creat
categori
donor
donor
deferr
polici
screen
test
match
polici
govern
life
exercis
biopow
women
posit
tie
reproduct
work
reproduct
potenti
within
increasingli
globalis
commerci
blood
economi
busbi
et
al
circumst
polici
rational
posit
remain
unclear
lack
transpar
